Literature review on breast cancer-related lymphedema and related factors

Q4 Medicine
Shaimaa Shamoun, Muayyad Ahmad
{"title":"Literature review on breast cancer-related lymphedema and related factors","authors":"Shaimaa Shamoun, Muayyad Ahmad","doi":"10.2298/aoo230313003s","DOIUrl":null,"url":null,"abstract":"A potential complication that affects a patient's quality of life is breast Cancer-related lymphedema (BCRL). Due to lymphatic system failure brought on by breast Cancer treatment, it is secondary lymphedema. This literature review examines 50 articles that are connected to BCRL. Research conducted in the English language between 2017 and 2022 is included. The definition, occurrence, severity, symptoms, risk factors, aspects of quality of life, and total decongestive therapy are all incorporated in this review of BCRL. The severity of the BCRL is assessed using International Staging Lymphology, 2020 from mild to severe. The documented incidence rates of BCRL in the literature range greatly, between less than 5% and more than 50%. The most significant risk factors of BCRL are related to lymph node surgery, in particular, axillary lymph node excision, and radiation therapy. If BCRL is not properly diagnosed and managed, it could have debilitating, long-lasting and late crippling side-effects of breast Cancer treatment. It frequently has a devastating impact on the quality of life in many domains. To better understand the behaviors and management of lymphedema risk reduction, patients with breast Cancer need extra information. To evaluate the effectiveness of complete decongestive therapy as a risk reduction behavior rather than for management and treatment, more study needs be done with a larger sample and longer supervision.","PeriodicalId":35645,"journal":{"name":"Archive of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archive of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2298/aoo230313003s","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

A potential complication that affects a patient's quality of life is breast Cancer-related lymphedema (BCRL). Due to lymphatic system failure brought on by breast Cancer treatment, it is secondary lymphedema. This literature review examines 50 articles that are connected to BCRL. Research conducted in the English language between 2017 and 2022 is included. The definition, occurrence, severity, symptoms, risk factors, aspects of quality of life, and total decongestive therapy are all incorporated in this review of BCRL. The severity of the BCRL is assessed using International Staging Lymphology, 2020 from mild to severe. The documented incidence rates of BCRL in the literature range greatly, between less than 5% and more than 50%. The most significant risk factors of BCRL are related to lymph node surgery, in particular, axillary lymph node excision, and radiation therapy. If BCRL is not properly diagnosed and managed, it could have debilitating, long-lasting and late crippling side-effects of breast Cancer treatment. It frequently has a devastating impact on the quality of life in many domains. To better understand the behaviors and management of lymphedema risk reduction, patients with breast Cancer need extra information. To evaluate the effectiveness of complete decongestive therapy as a risk reduction behavior rather than for management and treatment, more study needs be done with a larger sample and longer supervision.
乳腺癌相关淋巴水肿及相关因素的文献综述
影响患者生活质量的潜在并发症是乳腺癌相关淋巴水肿(BCRL)。由于乳腺癌治疗引起的淋巴系统衰竭,是继发性淋巴水肿。本文献综述分析了50篇与BCRL相关的文章。2017年至2022年期间用英语进行的研究也包括在内。BCRL的定义、发生、严重程度、症状、危险因素、生活质量各方面以及完全去充血治疗均纳入本综述。BCRL的严重程度采用国际分期淋巴学(International分期lymphoma, 2020)进行评估,从轻度到重度。文献记载的BCRL发病率范围很大,从小于5%到大于50%不等。BCRL最重要的危险因素与淋巴结手术,特别是腋窝淋巴结切除和放疗有关。如果BCRL没有得到正确的诊断和管理,它可能会造成乳腺癌治疗的衰弱、持久和晚期致残的副作用。它经常对许多领域的生活质量造成毁灭性的影响。为了更好地了解降低淋巴水肿风险的行为和管理,乳腺癌患者需要额外的信息。为了评估完全去充血性治疗作为降低风险行为的有效性,而不是用于管理和治疗,需要进行更多的研究,样本量更大,监督时间更长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Archive of Oncology
Archive of Oncology Medicine-Oncology
CiteScore
0.60
自引率
0.00%
发文量
5
审稿时长
12 weeks
期刊介绍: Archive of Oncology is an international oncology journal that publishes original research, editorials, review articles, case (clinical) reports, and news from oncology (medical, surgical, radiation), experimental oncology, cancer epidemiology, and prevention. Letters are also welcomed. Archive of Oncology is covered by Biomedicina Vojvodina, Biomedicina Serbica, Biomedicina Oncologica, EMBASE/Excerpta Medica, ExtraMED and SCOPUS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信